We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Synlab Group Selects Bruker´s MALDI Biotyper System for MS-based Molecular Microbial Identification

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Synlab Group Selects Bruker´s MALDI Biotyper System for MS-based Molecular Microbial Identification"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
At the KMIS meeting on Dec. 3-5, 2009 in Berlin, Bruker Daltonics announces a framework agreement with Synlab concerning molecular microbial identification based on MALDI-TOF mass spectrometry.

Synlab and Bruker have concluded a long-term partnership agreement in order to equip the laboratories of the Synlab association exclusively with the MALDI Biotyper system for molecular microbial identification.

The MALDI Biotyper is currently already in routine use in Synlab’s clinical microbiology centers in Trier, Weiden and Dachau in Germany. Moreover, Bruker and Synlab intend to further enlarge and refine the MALDI Biotyper reference library using well defined clinical isolates from the daily microbiology routine work of the Synlab laboratories.

The MALDI Biotyper is integrated into the Synlab laboratories’ microbiology workflow, combining fast molecular identification with conventional antibiotic susceptibility testing (AST). The MALDI Biotyper reports the identification results into the existing laboratory information systems (LIS). Integration with LIS MCS, Medat and Vision4health has already been established for Synlab, while integration with other LIS providers is also possible.

Dr. Ulrich Knipp, Technical Head of Microbiology at Synlab in Trier, commented: “After evaluating the MALDI Biotyper very thoroughly within the Synlab group, we are convinced that Bruker Daltonics is the most reliable partner for microbial identification based on mass spectrometry, and is providing outstanding microbiological service and support. Bruker Daltonics is fully established in the clinical microbiology market, and the MALDI Biotyper fulfils our requirements for reliability and robustness. The MALDI Biotyper represents a clear milestone substantiating our high quality molecular microbiology diagnostics.”